AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05899660 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Active Comparator: Omega-3
Description: It is a dietary supplement made of fish oil rich in n-3 PUFA.
Study NCT05899660 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Comparator: olive oil
Description: Refined olive oil is the usual placebo used in studies with n-3 PUFA.
Study NCT04939636 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin D3 capsules 4000IU/100µg.
Description: Vitamin D3 supplementation
Study NCT04939636 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin D3 capsules 600IU/15µg.
Description: Vitamin D3 supplementation
Study NCT05989373 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Scratch collapse test
Description: Scratch test performed by the surgeon but with a dynamometer
Study NCT05420441 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Phonophoresis with chitosan
Description: Patients in this group will receive chitosan through phonophoresis plus conventional treatment. For the phonophoresis parameters: pulsed ultrasonic waves (25%) of 1 MHz frequency and 1 W/cm2 intensity applied with a 5 cm diameter transducer. The total time of ultrasound application was eight minutes.Patients will also receive conventional Physical therapy program
Study NCT05420441 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Phonophoresis with glucoasmine
Description: Patients in this group will receive glucosamine through phonophoresis plus conventional treatment. For the phonophoresis parameters: pulsed ultrasonic waves (25%) of 1 MHz frequency and 1 W/cm2 intensity applied with a 5 cm diameter transducer. The total time of ultrasound application was eight minutes.Patients will also receive conventional Physical therapy program.
Study NCT05420441 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Conventional Physical Therapy
Description: Patients in the control group will receive the conventional treatment for knee osteoarthritis only, which will include the application of TENS, pulsed ultrasound, infrared light and exercise.
Study NCT05420441 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Physical Therapy
Description: Patients in the control group will receive the conventional treatment for knee osteoarthritis only, which will include the application of TENS, pulsed ultrasound, infrared light and exercise.
Study NCT06364241 — intervention group
Intervention type: OTHER
Intervention: Focus group
Description: During the focus group, the investigators will explore the cognitive deficits that people with lived experience with psychosis and their carers consider to be the most impairing.
Study NCT05684562 — intervention group
Intervention type: OTHER
Intervention: Cardiopulmonary exercise test
Description: CPET, the gold standard, will be used in the assessment of cardiorespiratory fitness. The cardiopulmonary exercise test system (Cosmed Quark CPET, Rome, Italy) is a safe method in which the patient can be monitored via ECG during the execution of the individual on a treadmill, and simultaneously lactate measurement, maximal O2 consumption, and CO2 production are evaluated. The Bruce protocol is the most commonly used method for KPET applied with a treadmill. However, since the Bruce protocol prefers high workload preferences, the Modified Bruce/half Bruce protocol with intermediate increments will be used. In addition, dyspnea, leg fatigue, and general fatigue at rest, during the test, and during the recovery phases after the test will be recorded with a sphygmomanometer using the Modified Borg Scale.
Study NCT05684562 — intervention group
Intervention type: OTHER
Intervention: Pulmonary function test
Description: Pulmonary function testing will be performed with a spirometer (Cosmed Quark CPET, Rome, Italy) connected to the CPET system using standard procedures. Forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), FEV1/FVC, peak expiratory volume measured at 25% and 75% of forced expiratory time (FEF 25-75%), and peak expiratory volume (PEF) parameters will be saved.
Study NCT05684562 — intervention group
Intervention type: OTHER
Intervention: Respiratory muscle strength test
Description: Intraoral maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP) will be used as indicators of respiratory muscle strength. A portable intraoral pressure gauge (MicroRPM, Micromedical, Kent, UK) and nose clip will be used during MIP and MEP assessments. MIP and MEP measurements will be obtained using standard procedures. 3 measurements will be made where the difference between each measurement is not more than 10% and the maximum value of MIP and MEP will be recorded.
Study NCT04684082 — intervention group
Intervention type: DEVICE
Intervention: Colonic irrigation with the Colon Hydromat
Description: A designated health professional will administer to the patient the colonic irrigation procedure - using the Colon Hydromat device, a CE certified device for colonic irrigation and cleansing before endoscopic procedures.
Study NCT05915728 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gadoquatrane (BAY1747846)
Description: 0.04 mmol Gd/kg body weight, solution for intravenous injection, single dose
Study NCT05915728 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gadobutrol
Description: Approved standard of care macrocyclic GBCA, 0.1 mmol Gd/kg body weight, solution for intravenous injection, single dose
Study NCT05915728 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gadoterate meglumine
Description: Approved standard of care macrocyclic GBCA, 0.1 mmol Gd/kg body weight, solution for intravenous injection, single dose
Study NCT05915728 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gadoteridol
Description: Approved standard of care macrocyclic GBCA, 0.1 mmol Gd/kg body weight, solution for intravenous injection, single dose
Study NCT06146790 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: endovascular treatment
Description: For the subjects randomized to endovascular treatment (EVT) treatment initiation is defined as the date and time of arterial puncture. Ideally, femoral artery puncture will occur within 30 minutes of randomization and no longer than 60 minutes after the completion of the qualifying imaging. Treatment initiation (arterial puncture) must occur before 24 hours since the subject was last known well.Date and time of arterial puncture, revascularization, and procedure end will be recorded. It is expected that the interventional procedure will be completed within two (2) hours of arterial access. If an appropriate thrombus or residual stenosis is identified, the choice of EVT strategy will be made by the treating neurointerventionalist. All mechanical thrombectomy devices for EVT, which are approved by CFDA for this purpose, are allowed in the trial.
Study NCT06146790 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard medical management
Description: Standard medical management
Study NCT05335005 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-2060
Description: MK-2060 administered via IV infusion
Study NCT05329649 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CTX001
Description: Administered by intravenous infusion following myeloablative conditioning with busulfan.
Study NCT05284006 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Imaging, gait analysis, growth, joint test, hearing test, questionnaire, etc.
Description: This study includes 15 major assessments: clinical assessment procedures; anthropometric measurements; activity of daily living and quality-of-life questionnaires; gait kinematics and kinetics analysis; pulmonary function tests (PFT); skeletal radiographs and dual-energy x-ray absorptiometry (DXA); MRI in cervical spine, temporal bones, and hip; computed tomography angiography (CTA) for tracheal obstruction; CT for temporal bones; anesthetic encounters; joint mobility; hearing function; biochemical analyses; and pathological analyses.
Study NCT03170947 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Custom Insoles
Description: Custom insoles will make with CAD-CAM using a laser scanning and casting for its construction. All this needs the assistance of a computer. From the digital image of a positive of the limb in foam the insole will be obtained.~Custom insoles make with direct adaptation technique (TAD) being of pvc resin. Once the resins are cut and with a temperature of 90º, they will be adapted to the foot (which will be protected with a sock) of the patient with the help of a vacuum. To this technique subtalar joint will be in a neutral position and metatarsal joints will be aligned.
Study NCT03170947 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standardized insoles
Description: Standardized insoles were done by EVA material with shore of 18 and 180 kg/cm3 and manufactured, with an extension of 3/4. It was in contact with heel and plantar arch.
Study NCT05736445 — intervention group
Intervention type: BEHAVIORAL
Intervention: Wellness coaching plus app use
Description: Participants will participate in wellness coaching and interact with apps on their smartphones
Study NCT04767802 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PTG-300
Description: Hepcidin mimetic
Study NCT04885114 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Intraparenchymal rAAV1 - (mi)RNA HTT
Description: Single dose MRI guided intraparenchymal infusion of rAAV1 - (mi)RNA HTT.
Study NCT05050734 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Comprehensive Behavioral Intervention for Tics - Enhanced (CBIT-E)
Description: Behavioral treatment for persistent tic disorders.
Study NCT04901351 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Smear
Description: In addition to the routine gynecological follow-up including a cervico-vaginal smear and an HPV test (HPV-HR genome detection), the doctor will propose prospectively to all consecutive patients who meet the inclusion criteria, during a follow-up consultation (post treatment of cervical dysplasia), to participate in the study, that is to have 2 other anal and ENT samples for an HPV test
Study NCT06142877 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social Media Use Reduction
Description: Participants will be incentivized to reduce their social media use by a pre-specified percentage from baseline.
Study NCT05290610 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Functional mapping
Description: Intracranial EEG data acquisition, observation and behavioral testing, and intracranial electrical stimulation
Study NCT04922996 — intervention group
Intervention type: DRUG
Intervention: Calcium Dobesilate
Description: Dosage of calcium dobesilate in different tissues
Study NCT05969821 — intervention group
Intervention type: OTHER
Intervention: observational cohort study
Description: observational cohort study
Study NCT06041958 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy
Description: 2 times/week for 12 weeks
Study NCT06041958 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pulse electromagnetic field therapy
Description: 2 times/week for 12 weeks
Study NCT06041958 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Rehabilitation
Description: 2 times/week for 12 weeks
Study NCT06058390 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bepirovirsen
Description: Bepirovirsen will be administered.
Study NCT05912478 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Videogame-Based Therapy
Description: The Nintendo Switch (Version 2) will be used to play video games. Within the scope of the study, Nintendo Switch games were analyzed with respect to their technical and fictional characteristics, required and optional movement patterns, difficulty levels, transitions between difficulty levels, and compatibility with priority problems. The selected activities will prioritize the activation of the scapular muscles. Throughout the activities, the participant will be required to mimic the on-screen avatar's movements. The player will receive a higher score if his or her movements in the game resemble the avatar's in terms of angular, velocity, and fluidity.
Study NCT05912478 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Waiting list
Description: The participants who were placed on a waiting list for eight weeks and constituted the control group will be asked to carry on with their normal activities. Participants in the control group will be contacted by phone in the fourth week to inquire about their status and to remind them that the exercise program will begin in the coming weeks. At the end of the 8-week study, the participants from the control group will participate in the exercise program.
Study NCT04541108 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rilvegostomig
Description: Intratumoral microdose injection by the CIVO device.
Study NCT04541108 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Volrustomig
Description: Intratumoral microdose injection by the CIVO device.
Study NCT04541108 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Sabestomig
Description: Intratumoral microdose injection by the CIVO device.
Study NCT04541108 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Intratumoral microdose injection by the CIVO device.
Study NCT05627310 — intervention group
Intervention type: OTHER
Intervention: Diagnostic
Description: Training dataset was used to train the deep learning model, which was validated and tested by external dataset.
Study NCT04782895 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58 )Vaccine(E.Coli)
Description: Three doses administered intramuscularly at 0, 45 day and 6 month.
Study NCT04782895 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Gardasil®9
Description: Three doses administered intramuscularly at 0, 45 day and 6 month.
Study NCT06457412 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention group for the treatment of childhood obesity
Description: Intervention for children aged 6 to 12 years with childhood obesity (with a BMI greater than the 99th percentile), fostering motivation and encouraging changes toward healthy lifestyle habits to achieve greater adherence and to improve health. The program comprises 9 educational sessions designed by specialized professionals (code of Spanish register: 2007144741729) to be conducted in a health center. The sessions will be held every 15 days, with a duration of 90 minutes for a group of 10 children and another group of 10 family members and/or caregivers. Professionals from different disciplines (paediatricians, psychologists, nurses and nutritionists), will meet with groups of pediatric patients and in another group with their family members or primary caregivers.
Study NCT05168605 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home visit
Description: Patients receiving home Visits
Study NCT05102123 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cytisine
Description: Listed as a natural health product in Canada, cytisine is utilized to aid in smoking cessation
Study NCT05102123 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytisine
Description: Listed as a natural health product in Canada, cytisine is utilized to aid in smoking cessation
Study NCT05102123 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Video Messaging
Description: Supportive messaging utilizing a video messaging platform to encourage patients to abstain from smoking throughout the treatment period.
Study NCT05102123 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Video Messaging
Description: Supportive messaging utilizing a video messaging platform to encourage patients to abstain from smoking throughout the treatment period.
Study NCT05529784 — intervention group
Intervention type: DRUG
Intervention: Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT]
Description: Dupilumab 300mg in pre-filled injector Q2W
Study NCT06626100 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise-themed game
Description: The intervention includes three parts: quiz questions on knowledge on and benefits of exercise; monitored step count using smartphone tracker; whatsapp reminders on the benefits of exercise.
Study NCT06626100 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Diet-themed game
Description: The intervention includes two parts: quiz questions on knowledge on and benefits of healthy diet; whatsapp reminders on the benefits of healthy diet.
Study NCT05056701 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: annual follow-up during 10 years
Description: an annual follow-up is carried out systematically for a total of 10 years in order to detect the subsequent occurrence of CKD
Study NCT06088355 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HV-PDAE: High Volume Partnered Dance Aerobic Exercise
Description: HV-PDAE classes will meet 5 times a week for 90 minute sessions for 3 weeks at onset of trial and then every 4 weeks for a year. All participants will receive 112.5h of training. PDAE was adapted for older adults with balance impairments; modifications were made to the frame and steps of Argentine tango. People with PD partner an individual without PD, e.g., staff, caregiver, friend, or university student. The instructor, staff lead and assistants monitor participants for safety. Class sizes will consist of 6 or fewer pairs of participants with PD and partners. Participants with PD will dance with new partners (individuals without PD) every 15-20 minutes. Participants will learn new steps in each class. The class format includes practicing steps, warm-up, partnering and rhythmic exercises, learning new steps, combining old and new steps, cool down. PDAE classes follow a syllabus with new steps, rhythms and embellishments included in each class.
Study NCT06088355 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: MV-PDAE: Moderate Volume Partnered Dance Aerobic Exercise
Description: MV-PDAE: MV classes will meet biweekly for 52 weeks for 65-minute sessions. All participants will receive 112.5h of training. . PDAE was adapted for older adults with balance impairments; modifications were made to the frame and steps of Argentine tango. People with PD partner an individual without PD, e.g., staff, caregiver, friend, or university student. The instructor, staff lead and assistants monitor participants for safety. Class sizes will consist of 6 or fewer pairs of participants with PD and partners. Participants with PD will dance with new partners (individuals without PD) every 15-20 minutes. Participants will learn new steps in each class. The class format includes practicing steps, warm-up, partnering and rhythmic exercises, learning new steps, combining old and new steps, cool down. PDAE classes follow a syllabus with new steps, rhythms and embellishments included in each class.
Study NCT06088355 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: MV-WALK: Moderate Volume Walking
Description: MV-WALK (65-minute sessions): WALK will control for the walking that participants in PDAE do and will also take place in groups to control social effects of intervention. Walking for
Study NCT05204316 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Digital Analysis of Speech
Description: Recordings will be transcribed manually to written digital text formats, on which NLP tools such as tokenisation and lexical analysis will be performed.
Study NCT05625945 — intervention group
Intervention type: BEHAVIORAL
Intervention: Physical activity monitoring
Description: Physical activity patterns will be measured using the activPAL3 micro monitor
Study NCT05631691 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Support for Students exposed to Trauma Program
Description: Support for students exposed to trauma program (SSET) is a school-based intervention program for students who have been exposed to traumatic events and exhibit signs of post-traumatic stress disorder (PTSD). (Jaycox, Langley, \& Dean, 2009; Jaycox, Langley, Stein et al., 2009). SSET is specifically designed for school teachers, school counsellors, and other non-clinical staff. SSET program is a series of 10 structured lessons designed to reduce post-traumatic and depressive symptoms and improve functioning in school children exposed to traumatic events. it includes psycho-education, relaxation, cognitive restructuring, social problems solving and behavioral exposure.
Study NCT06133114 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clonazepam
Description: 0.5 mg twice a day (1 mg a day)
Study NCT06133114 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olanzapine
Description: 2.5 mg once a day of Olanzapine
Study NCT06133114 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Buprenorphine
Description: 2 mg once a day of Buprenorphine
Study NCT05809349 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcranial magnetic stimulation
Description: The stimulation intensity will be 80% resting motor threshold (RMT). The theta burst stimulation (cTBS) with a frequency at 50Hz, repeated at 5Hz, are delivered in a duration of 33.2s with the number of stimulation pulses of 600. Two groups of stimulation will be repeated in each cerebellar dentate nucleus with an interval of 5 min in each group. The treatment will last for 2 weeks, with 5 times per week.
Study NCT05905419 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Opioid Phase
Description: Opioid-taking patients are assigned to take their prescribed opioid medication before (peak opioid phase) during 1 scan and after (trough opioid phase) during the other MRI scan
Study NCT04919174 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remimazolam
Description: Sedation with remimazolam
Study NCT04919174 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine
Description: Sedation with dexmedetomidine
Study NCT04141020 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Microsurgical clipping
Description: Standard of care microsurgical clipping of an unruptured cerebral artery aneurysm.